| Term 
 
        | Min. # of drugs Tb pts should be on? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Types of therapy that cause/prevent resistance? |  | Definition 
 
        | Cause: monotherapy Prevent: combo therapy
 |  | 
        |  | 
        
        | Term 
 
        | Development of resistance indicates what? |  | Definition 
 
        | worse prognosis AND more severe disease |  | 
        |  | 
        
        | Term 
 
        | How do you handle a failing regimen? |  | Definition 
 
        | Put pt on at least 2 drugs they have NEVER had. DO NOT add a single drug to the failing regimen
 |  | 
        |  | 
        
        | Term 
 
        | 2 categories of therapy you must have in order to effectively treat Tb? |  | Definition 
 
        | 1) Early bactericidal therapy (stop the bugs from growing) AND 2) sterilizing activity (kill off the remaining bugs) |  | 
        |  | 
        
        | Term 
 
        | Reasoning behind giving BACTERICIDAL and STERILIZING therapy at the same time during the first 2 months? |  | Definition 
 
        | Shortens treatment time (6 instead of 9 mo) AND dec chance of relapse |  | 
        |  | 
        
        | Term 
 
        | Why does relapse usually occur? |  | Definition 
 
        | Tissues were not properly STERILIZED |  | 
        |  | 
        
        | Term 
 
        | Most common drug combo for the first 2 months (bactericidal)? 
 Why do we use this combo?
 |  | Definition 
 
        | RIPE -- we  don't know the sensitivity of the Tb so we use all 4 and hope the drug is sensitive to 2 or 3 of them Rifampin (RIF)
 Isoniazid (INH)
 Pyrazinamide (PZA)
 Ethambutol (EMB)
 |  | 
        |  | 
        
        | Term 
 
        | What do you if during the first 2 months, your pt is on RIPE, and the Tb comes back being INH sensitive? |  | Definition 
 
        | Stop the EMB (dec chances of SE - vision)!  Continue the other 3 
 You only start them on EMB just in case the Tb is INH resistant.
 |  | 
        |  | 
        
        | Term 
 
        | Of RIPE, which 2 are the best sterilizers? |  | Definition 
 
        | RIF and PZA 
 (both are cidal)
 |  | 
        |  | 
        
        | Term 
 
        | If you were not able to use PZA during the first 2 months, how long does your pt have to be on Tb drugs? |  | Definition 
 
        | 9 
 Pts can only do 6 months of treatment if they have been able to be on PZA the entire first 2 months b/c PZA is a really good STERILIZER, so if you couldn’t sterilize for the first 2 months, must inc the sterilization period (7 months)
 |  | 
        |  | 
        
        | Term 
 
        | Why wouldn't someone be able to be on PZA? |  | Definition 
 
        | Liver problems, gout, pregnant |  | 
        |  | 
        
        | Term 
 
        | After 2 months of therapy w/ RIP (the bug was INH sensitive, so we dropped the EMB) -- what do you do next? |  | Definition 
 
        | Drop the PZA and continue the RIF and INH for 4 more months 
 Pts will either take it daily, twice weekly, or three times weekly (depending on HIV+/immunocompromised)
 
 If HIV-negative, absence of cavitary disease at presentation, and negative sputum smears at 2 months of therapy then: 1x/week INH-rifapentine
 |  | 
        |  | 
        
        | Term 
 
        | What do you do if the pt can't take RIF? |  | Definition 
 
        | Use PZA throughout the course instead 
 [I'm not sure how long it would have to be.. my guess is probably the longer (9 mo) but I'm not sure]
 |  | 
        |  | 
        
        | Term 
 
        | Most active of all the Tb drugs? |  | Definition 
 
        | INH 
 (one 1 that is both static AND cidal)
 |  | 
        |  | 
        
        | Term 
 
        | Quick and dirty summary of Tb treatment |  | Definition 
 
        | 1) 2 months: RIPE --drop the EMB if INH sensitive
 2) 4 (or 7) months: RIF & INH
 
 ***use PZA throughout treatment if can’t use RIF
 |  | 
        |  | 
        
        | Term 
 
        | What types of bacteria is RIF effective against? |  | Definition 
 
        | mycobacteria, most Gram-positive and many gram negative bacteria |  | 
        |  | 
        
        | Term 
 
        | Which one is more selective: INH or RIF? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibition of DNA-dependent RNA polymerase → inhibits the synthesis of RNA ***must be in high concentrations to do this!
 |  | 
        |  | 
        
        | Term 
 
        | Which Tb drugs have intracellular AND extraceullar activity? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Why do you need to give RIF 2x/wk? |  | Definition 
 
        | to avoid a flu-like syndrome of fever, chills and myalgia |  | 
        |  | 
        
        | Term 
 
        | Which Tb drug has the SE of: 	red-orange color to the urine, feces, saliva, sweat and tears? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | rash, fever, nausea and vomiting 
 Also: induces several P450 isoforms
 |  | 
        |  | 
        
        | Term 
 
        | How is RIF self destructive? |  | Definition 
 
        | when administered over longer periods could cause CYP3A auto induction reducing its own systemic exposure |  | 
        |  | 
        
        | Term 
 
        | Why do you have monitor RIF in ppl with liver problems? 
 What other Tb drug do you need to monitor for liver function?
 |  | Definition 
 
        | excreted mainly in bile and is subject to enterohepatic recirculation 
 Other drug: EMB -- 1/2 is excreted in urine and 1/2 in the bile so renal and hepatic function must be monitored
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which Tb drug(s) is a pro drug? |  | Definition 
 
        | INH & PZA 
 INH: activated by catalase-peroxidase (KatG gene)
 Deletions or mutations in this gene --> resistance to INH
 
 PZA: metabolized by mycobacteria (nicotinamidase) to pyrazinoic acid (active form)
 **only active in acidic places (the edge of necrotic TB where lactic is b/c of inflamm. cells)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | disrupts cell wall synthesis 
 by inhibiting the enzymes
 --enoyl acyl carrier protein reductase --β-ketoacyl-ACP synthase
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | BOTH! cidal - growing bacteria
 static - resting bacteria
 |  | 
        |  | 
        
        | Term 
 
        | How does renal/hepatic impairment affect the toxicity of INH? |  | Definition 
 
        | metabolized partly by acetylation b/c it's a hydrazine 
 If pt is a slow acetylator, then renal/hepatic impairment → inc toxicity
 
 (***PAS also metabolized by acetylation)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hepatitis (inc during pregnancy), lupus like syndrome,  convulsions, peripheral neuritis 
 ***Also: inhibits cytochrome P450
 |  | 
        |  | 
        
        | Term 
 
        | True or False INH and RIF inhibit cytochrome P450
 |  | Definition 
 
        | FALSE INH inhibits but RIF INDUCES
 
 Yeah.. I just Parsaed you :)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | They can't decide: 
 either by
 1)inhibiting transcription of the mycobacterial fatty acid synthase I (FASI) gene or
 2)inhibiting FAS1 itself
 |  | 
        |  | 
        
        | Term 
 
        | If FAS1 isn't allowed to do it's job, what happens? |  | Definition 
 
        | interference with (a) mycolic acid synthesis,
 (b) reduction of intracellular pH and (c) disruption of membrane transport by POAH (the protonated form of POA- (pyrazinoic acid))
 |  | 
        |  | 
        
        | Term 
 
        | SE of PZA? 
 What SE does EMB share with PZA?
 |  | Definition 
 
        | hepatotoxicity, hyperuricemia (can't excrete uric acid) --> acute gout 
 arthralgias, nausea, vomiting and fever
 
 EMB also has hyperuricemia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits arabinosyltransferase --> disrupts cell wall synthesis |  | 
        |  | 
        
        | Term 
 
        | How does EMB work with the other Tb drugs? |  | Definition 
 
        | disrupts the cell wall thus increasing the penetration of other antiTb drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | retrobulbar neuritis 
 causing red-green color blindness and loss of visual acuity
 |  | 
        |  | 
        
        | Term 
 
        | How is Rifabutin like RIF?  Different? |  | Definition 
 
        | Derivative of RIF w/ same mechanism of action 
 Diff: less potent inducer of cytochrome P450, has SE: polymyalgia, pseudojaundice and anterior uveitis
 |  | 
        |  | 
        
        | Term 
 
        | How does Rifapentine compare to RIF and Rifabutin? 
 (1/2 life? P450?)
 |  | Definition 
 
        | --Longer 1/2 life than other 2 --In between the 2 for inducing cytochrome P450
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | interferes with cell wall synthesis 2 ways: 
 1) inhibits alanine racemase
 2) inhibits D-ala-D-ala synthetase
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | serious CNS toxicity, headache, tremors, psychoses and convulsions |  | 
        |  | 
        
        | Term 
 
        | ETHIONAMIDE has MOA like which of the 4 big Tb drugs? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | gastric irritation, hepatotoxicity, peripheral neuropathies and optic neuritis |  | 
        |  | 
        
        | Term 
 
        | 3 aminoglycosides that are also antiTb? |  | Definition 
 
        | Streptomycin, Kanamycin, and Amikacin 
 **Capreomycin is not an AG (it's amixture of four active cyclic peptides)
 |  | 
        |  | 
        
        | Term 
 
        | Streptomycin: cidal or static? 
 Extracellular or intracellular?
 |  | Definition 
 
        | Cidal in vivo (some evidence suggests static in vivo too..) 
 Extracellular
 |  | 
        |  | 
        
        | Term 
 
        | How does Streptomycin compare to other Tb drugs? |  | Definition 
 
        | less effective and more toxic than other drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits initiation of protein synthesis, causes misreading of mRNA → synthesis of faulty proteins and it causes premature termination of protein synthesis by breaking polysomes into nonfunctional monosomes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nephrotoxicity (reversible) and ototoxicity |  | 
        |  | 
        
        | Term 
 
        | How do Amikacin/kanamycin compare to streptomycin? |  | Definition 
 
        | less toxic similar MOA
 same SEs as streptomycin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Levofloxacin, Moxifloxacin, Gatifloxacin 
 ..no CIPRO
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits bacterial DNA gyrase (bacterial eq. of mammallian topoisomerase II which prevents supercoiling) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SE: nausea, headache, dizziness, rash and pseudomembranous colitis (C. difficile) |  | 
        |  | 
        
        | Term 
 
        | How is CAPREOMYCIN administered? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits protein synthesis but how is unclear |  | 
        |  | 
        
        | Term 
 
        | CAPREOMYCIN: static or cidal? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Why can't you give CAPREOMYCIN w/ streptomycin? |  | Definition 
 
        | B/c both are nephrotoxic and ototoxic 
 **Same rule goes for the other AGs kanamycin and amikacin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nephrotoxic and ototoxi eosinophilia, which is common, hearing loss and tinnitus.
 |  | 
        |  | 
        
        | Term 
 
        | Which 2 drugs are given when the first line agents (RIPE and other 2 Rif's) can't be used? |  | Definition 
 
        | CAPREOMYCIN, PARA-AMINOSALICYLIC ACID (PAS) |  | 
        |  | 
        
        | Term 
 
        | MOA of PARA-AMINOSALICYLIC ACID (PAS)? |  | Definition 
 
        | PAS competes with p-aminobenzoic acid in the synthesis of folic acid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | static 
 Think about MOA: competes with p-aminobenzoic acid in the synthesis of folic acid.. this prevents growth/reproduction but doesn't kill the bugs that are already there
 |  | 
        |  | 
        
        | Term 
 
        | How does PAS affect INH levels? |  | Definition 
 
        | Both metabolized by acetylation --> PAS competes with INH for the metabolizing enzymes thus increasing the levels of INH |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nausea, vomiting, diarrhea, anorexia, epigastric pain, abdominal distress, fever, malaise or joint pain. High drug concentrations in urine can cause crystalluria |  | 
        |  | 
        
        | Term 
 
        | Difference b/t cidal and static? |  | Definition 
 
        | Static -- the drug simply STOPS growth/reproduction.. it does not harm the bugs that are already there (1000 bugs will stay at 1000 bugs, can not increase but also, will not go down to 0) 
 Cidal -- Drugs actually KILLS the bugs that currently exist (1000 bugs will eventually go to 0 bugs)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | INH (both static and cidal) EMB
 FQ
 CAPREOMYCIN
 PAS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | INH (both static and cidal) RIF
 PZA
 Streptomycin (in vivo)
 |  | 
        |  |